Testing a stool-based screening for colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new stool-based screening test that may find colorectal cancer and advanced adenomas (precancerous growths) early. It studies whether the test works well compared with the standard colonoscopy, so it could offer an easier, less invasive screening option in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 45 years or older.
- Your doctor must have advised you to have a screening colonoscopy (a test that looks inside your colon for early signs of cancer).
- You must be at average risk for colorectal cancer, meaning you haven't had colorectal polyps, colorectal cancer, or inflammatory bowel disease before.
- You must not have a personal or family history of genetic conditions that increase colorectal cancer risk, like Lynch syndrome or FAP.
- You must provide a stool sample within 90 days before your colonoscopy, and be able to undergo the colonoscopy afterward.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called Gixam to see if it can help find colorectal cancer in people who recently had a normal FIT test (a stool test for blood). You may be able to join if you are between 45 and 85 years old and are already scheduled for a routine screening colonoscopy.
This study is looking for people newly diagnosed with colorectal cancer or advanced adenoma to help find better ways to detect the disease early using advanced lab tests on blood samples.
This trial is testing a new way to screen for colorectal cancer in adults aged 45 to 74. If you join, you will help researchers find better methods for early detection.
This study looks at whether a simple blood test can help guide the care of people being evaluated for colorectal cancer. It may support earlier or clearer decision-making alongside existing screening or colonoscopy results.
This trial tests whether a stool blood test can help decide who truly needs a follow-up colonoscopy after prior colon polyps. It may reduce unnecessary colonoscopies while still catching concerning changes early.
This study is testing a new blood test (Signal-C) to see if it can help find colorectal cancer early. You may be able to join if you are average risk and getting a routine screening colonoscopy.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.